Research outputs
2025
Real world epidemiological trends in nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), England 2014-2021: Preliminary data from the uncover Study group
Karpha, I., Akter, N., Erinfolami, T., Abdulkareem, T., Lim, Y. J., Renshaw, H., . . . McKay, P. (2025). Real world epidemiological trends in nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), England 2014-2021: Preliminary data from the uncover Study group. BLOOD, 146, 6298-6299. doi:10.1182/blood-2025-6298
Respiratory syncytial virus (RSV) infection in adults with blood cancer: An England-wide population study
Lim, Y. J., Erinfolami, T., Akter, N., Abdulkareem, T., Ross, A., Johnston, B., . . . Pettitt, A. (2025). Respiratory syncytial virus (RSV) infection in adults with blood cancer: An England-wide population study. BLOOD, 146, 6402-6403. doi:10.1182/blood-2025-6402
The impact of frailty on real world outcomes for multiple myeloma patients in England - a cohort study from the uncover study group and ukmra frailty group.
Chandler, T., Karpha, I., Akter, N., Erinfolami, T., Liu, H., Johnston, B., . . . Cook, G. (2025). The impact of frailty on real world outcomes for multiple myeloma patients in England - a cohort study from the uncover study group and ukmra frailty group.. BLOOD, 146, 2792-2793. doi:10.1182/blood-2025-2792
Treatment intensity and region of diagnosis affect survival in primary CNS lymphoma in England: A national cohort study from the uncover project
Bishton, M., Akter, N., Karpha, I., Tayabali, S., Erinfolami, T., Smith, C. T., . . . Fox, C. (2025). Treatment intensity and region of diagnosis affect survival in primary CNS lymphoma in England: A national cohort study from the uncover project. BLOOD, 146, 6325-6326. doi:10.1182/blood-2025-6325
Frailty and Social Deprivation Affect Real-World Outcomes in Multiple Myeloma (MM) – an England-Wide Cohort Study from the UNCOVER Study Group and UKMRA Frailty Group
Chandler, T., Karpha, I., Akter, N., Erinfolami, T., Liu, H., Johnston, B., . . . Cook, G. (2025). Frailty and Social Deprivation Affect Real-World Outcomes in Multiple Myeloma (MM) – an England-Wide Cohort Study from the UNCOVER Study Group and UKMRA Frailty Group. Clinical Lymphoma Myeloma and Leukemia, 25, S264-S265. doi:10.1016/s2152-2650(25)03845-5
331 | INCIDENCE AND SURVIVAL OF PRIMARY CNS LYMPHOMA: AN ENGLAND‐WIDE COHORT STUDY FROM THE UNCOVER STUDY GROUP
Karpha, I., Tayabali, S., Akter, N., Erinfolami, T., Smith, C. T., Liu, H., . . . Bishton, M. (2025). 331 | INCIDENCE AND SURVIVAL OF PRIMARY CNS LYMPHOMA: AN ENGLAND‐WIDE COHORT STUDY FROM THE UNCOVER STUDY GROUP. Hematological Oncology, 43(S3). doi:10.1002/hon.70094_331
617 | INCIDENCE AND SURVIVAL OF MANTLE CELL LYMPHOMA IN ENGLAND 2014–2021: A NATIONAL COHORT STUDY FROM THE UNCOVER STUDY GROUP
Martin, A. L., Eyre, T., Karpha, I., Lim, Y. Y., Erinfolami, T., Akter, N., . . . Lewis, D. (2025). 617 | INCIDENCE AND SURVIVAL OF MANTLE CELL LYMPHOMA IN ENGLAND 2014–2021: A NATIONAL COHORT STUDY FROM THE UNCOVER STUDY GROUP. Hematological Oncology, 43(S3). doi:10.1002/hon.70096_617
96 | FOLLICULAR LYMPHOMA EPIDEMIOLOGY AND OUTCOMES IN ENGLAND 2014–2021: PRELIMINARY ANALYSIS FROM THE UNCOVER STUDY GROUP
Linton, K. M., Karpha, I., Lim, Y., Bishton, M., Jeffers, L., Erinfolami, T., . . . Pettitt, A. (2025). 96 | FOLLICULAR LYMPHOMA EPIDEMIOLOGY AND OUTCOMES IN ENGLAND 2014–2021: PRELIMINARY ANALYSIS FROM THE UNCOVER STUDY GROUP. Hematological Oncology, 43(S3). doi:10.1002/hon.70093_96
Variation in the use of primary care-led investigations prior to a cancer diagnosis: analysis of the National Cancer Diagnosis Audit
Akter, N., Lyratzopoulos, G., Swann, R., Rubin, G., Mcphail, S., Rafiq, M., . . . Abel, G. (2025). Variation in the use of primary care-led investigations prior to a cancer diagnosis: analysis of the National Cancer Diagnosis Audit. BMJ QUALITY & SAFETY, 34(6), 367-376. doi:10.1136/bmjqs-2024-017264
Factors affecting prostate cancer detection through asymptomatic prostate-specific antigen testing in primary care in England: evidence from the 2018 National Cancer Diagnosis Audit
Merriel, S. W. D., Akter, N., Zakkak, N., Swann, R., Mcphail, S., Rubin, G., . . . Abel, G. (2025). Factors affecting prostate cancer detection through asymptomatic prostate-specific antigen testing in primary care in England: evidence from the 2018 National Cancer Diagnosis Audit. BRITISH JOURNAL OF GENERAL PRACTICE, 75(754), e300-e305. doi:10.3399/BJGP.2024.0376
2024
Current experience and future potential of facilitating access to digital NHS primary care services in England: the Di-Facto mixed-methods study.
Abel, G., Atherton, H., Sussex, J., Akter, N., Aminu, A. Q., Bak, W., . . . Campbell, J. L. (2024). Current experience and future potential of facilitating access to digital NHS primary care services in England: the Di-Facto mixed-methods study.. Health and social care delivery research, 12(32), 1-197. doi:10.3310/jkyt5803
Exploring How Patients Are Supported to Use Online Services inPrimary Care in England Through "Digital Facilitation":SurveyStudy
Winder, R., Campbell, J. L., Akter, N., Aminu, A. Q., Lambert, J., Cockcroft, E., . . . Abel, G. (2024). Exploring How Patients Are Supported to Use Online Services inPrimary Care in England Through "Digital Facilitation":SurveyStudy. JOURNAL OF MEDICAL INTERNET RESEARCH, 26. doi:10.2196/56528
2022
The effect of hormone replacement therapy on the survival of UK women: a retrospective cohort study 1984-2017
Akter, N., Kulinskaya, E., Steel, N., & Bakbergenuly, I. (2021). The effect of hormone replacement therapy on the survival of UK women: a retrospective cohort study 1984-2017. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. doi:10.1111/1471-0528.17008